Spots Global Cancer Trial Database for vancomycin
Every month we try and update this database with for vancomycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders | NCT04729322 | Metastatic Colo... Metastatic Smal... Stage IV Colore... Stage IV Small ... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Biopsy Fecal Microbiot... Fecal Microbiot... Metronidazole Neomycin Nivolumab Pembrolizumab Questionnaire A... Vancomycin | 18 Years - | M.D. Anderson Cancer Center | |
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | NCT04983901 | Hematopoietic a... Malignant Solid... | Imipenem/Cilast... Cefepime Meropenem Piperacillin-Ta... Vancomycin Daptomycin Linezolid | 18 Years - | M.D. Anderson Cancer Center | |
Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | NCT03546829 | Early Stage Non... | Vancomycin Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection | NCT00035425 | Febrile Neutrop... | linezolid vancomycin | 13 Years - | Pfizer | |
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology | NCT04758442 | Vancomycin Hematologic Mal... Febrile Neutrop... | Additional bloo... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | NCT03546829 | Early Stage Non... | Vancomycin Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | NCT04983901 | Hematopoietic a... Malignant Solid... | Imipenem/Cilast... Cefepime Meropenem Piperacillin-Ta... Vancomycin Daptomycin Linezolid | 18 Years - | M.D. Anderson Cancer Center | |
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | NCT00296049 | Infection Neutropenia Unspecified Adu... Unspecified Chi... | daptomycin vancomycin | - 120 Years | Wake Forest University Health Sciences | |
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral | NCT04025567 | Metastatic Hepa... Hepatocellular ... | vancomycin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients | NCT03030248 | Clostridium Dif... Hematologic Dis... Bone Marrow Tra... Oncologic Disor... | Vancomycin Oral... Placebo Oral Ca... | 18 Years - | Medical College of Wisconsin | |
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | NCT04983901 | Hematopoietic a... Malignant Solid... | Imipenem/Cilast... Cefepime Meropenem Piperacillin-Ta... Vancomycin Daptomycin Linezolid | 18 Years - | M.D. Anderson Cancer Center | |
Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | NCT03546829 | Early Stage Non... | Vancomycin Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN | NCT04983901 | Hematopoietic a... Malignant Solid... | Imipenem/Cilast... Cefepime Meropenem Piperacillin-Ta... Vancomycin Daptomycin Linezolid | 18 Years - | M.D. Anderson Cancer Center | |
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders | NCT04729322 | Metastatic Colo... Metastatic Smal... Stage IV Colore... Stage IV Small ... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Biopsy Fecal Microbiot... Fecal Microbiot... Metronidazole Neomycin Nivolumab Pembrolizumab Questionnaire A... Vancomycin | 18 Years - | M.D. Anderson Cancer Center | |
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral | NCT04025567 | Metastatic Hepa... Hepatocellular ... | vancomycin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients | NCT00454272 | Infection Febrile Neutrop... | Teicoplanin Vancomycin | 2 Years - | Sanofi | |
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology | NCT04758442 | Vancomycin Hematologic Mal... Febrile Neutrop... | Additional bloo... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | NCT00296049 | Infection Neutropenia Unspecified Adu... Unspecified Chi... | daptomycin vancomycin | - 120 Years | Wake Forest University Health Sciences | |
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders | NCT04729322 | Metastatic Colo... Metastatic Smal... Stage IV Colore... Stage IV Small ... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Biopsy Fecal Microbiot... Fecal Microbiot... Metronidazole Neomycin Nivolumab Pembrolizumab Questionnaire A... Vancomycin | 18 Years - | M.D. Anderson Cancer Center |